$22.00
Manufacturer: Germany
Symptomatic treatment of conditions requiring binding of gastric acid: heartburn, acid regurgitation.
Description
Riopan (magaldrate) oral suspension 800 mg/10 ml. sachets №20
Composition
active substance: magaldrate;
- Riopan 800 mg in a sachet (10 ml) contains 800 mg of anhydrous magaldrate*;
- Riopan 1600 mg in a sachet (10 ml) contains 1600 mg of anhydrous magaldrate*;
auxiliary substances: acacia (gum arabic), hypromellose, maltol, sodium cyclamate, simethicone emulsion 30%**, silver sulfate (E 174), chlorhexidine digluconate solution 20%, cream flavoring, caramel flavoring, purified water.
* It is used in the form of a 10% magaldrate suspension.
Composition of 10% magaldrate suspension:
Magaldrate anhydrous, water, sodium hypochlorite.
** Composition of simethicone emulsion:
Simethicone, methylcellulose, sorbic acid, purified water.
Medicinal form
Oral suspension.
Main physical and chemical properties: white suspension with a creamy shade and caramel smell.
Pharmacotherapeutic group
Antacids. Combinations and complex compounds of aluminum, calcium and magnesium.
Code ATX A02A D02.
Pharmacological properties
This drug is included in a group of drugs based on a combination of substances used to treat diseases of the gastrointestinal tract, characterized by high acidity.
The drug is an antacid with carminative anti-flanulent components.
Magaldrat, one of the active components of this drug, has an antacid effect. Has the property of neutralizing hydrochloric acid secreted in the stomach to digest food. The higher the concentration of hydrochloric acid in the gastric juice, the higher its acidity and the higher the likelihood of developing undesirable phenomena – irritation of the walls of the stomach and intestines, the development of esophageal reflux, and others.
Under the influence of magaldrat, the activity of the main gastric enzyme, pepsin, decreases. Also, the drug is able to adsorb bile acid, as well as acids and lysolecithin.
Protects the stomach lining from the effects of stomach acids and enzymes.
Indications
This drug Riopan suspension is used to treat acidity. In particular, it is applied when:
- gastritis with high acidity;
- esophagitis, reflux esophagitis;
- heartburn (gastroesophageal reflux), a feeling of discomfort in the epigastric zone.
Also used as part of the complex treatment of gastric and duodenal ulcers.
Contraindications
The drug Riopan suspension in question is contraindicated for use in cases where the patient has severe hypersensitivity (allergy) to the main or one of the auxiliary components.
In liver failure, phosphate deficiency may develop, so caution should be exercised when prescribing this drug to this group of patients.
Application during pregnancy and lactation
This drug is not used in the treatment of pregnant women.
If it is necessary to take the drug during breastfeeding, then during treatment, lactation should be suspended.
Method of administration and dosage
Riopan suspension is taken orally, by mouth, an hour or two after eating.
The recommended dosage is 1-2 sachets per 1 dose.
Maximum per day is permissible to take no more than 8 sachets in a dosage of 800 mg or four sachets in a dosage of 1600 mg.
Before use, the sachet should be shaken vigorously or wrinkled between your fingers.
It should be borne in mind that this drug is intended for the treatment of symptoms, and does not eliminate the cause of the disease.
If, after 2 weeks of regular intake of the drug, the symptoms do not disappear, then you should seek medical help for an additional examination.
Old age is not a reason for dosage adjustments.
Patients should adhere to a diet with high acidity, regardless of the drug intake.
Overdose
Overdose has not been recorded at the moment.
In theory, it can cause an increase in the side effect in the form of intense diarrhea.
In this case, symptomatic treatment is recommended – gastric lavage, intake of enterosorbents, control of water balance.
Side effects
With prolonged use or exceeding the recommended duration of treatment, a side effect such as diarrhea may develop.
In addition, if the drug was used in patients with impaired renal function, then they may develop encephalopathy.
Also, as a result of intoxication with magnesium preparations, which is part of the drug, it is possible to develop shifts in metabolic processes occurring in bone tissue, in particular, in the form of osteopathy, osteomalacia. In particular, these side effects often develop in children.
Recent Reviews